30
Nov
2008
ArGentis Pharmaceuticals, LLC: $2M Series A
Posted in I - Series A, Q - 2Q08, R - SOUTH EAST, X - Autoimmune, X - Opthalmology, X - Wound Healing
ArGentis Pharmaceuticals (Memphis, TN) development-stage biopharmaceutical company focused the development of autoimmunity and ophthalmology therapeutics, closed a $2.0M Series financing. Participants include Innova Memphis.
OnBioVC PARTNERS
-
